Skip to main content

Chondrocyte Isolation and Expansion

  • Protocol
  • First Online:
Cartilage Tissue Engineering

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2598))

Abstract

Chondrocyte isolation requires a combination of enzymatic and mechanical digestion of cartilaginous tissues in order to release the chondrocytes. Extracted primary chondrocytes will then adhere to standard tissue culture plastics, typically in small clusters, over a period of a few days in monolayer culture. Chondrocyte populations are expanded in a basal medium containing serum, supplemented with ascorbic acid, antibiotics, and sometimes antifungal agents and growth factors. Here we describe the standard research grade and good manufacturing practice (GMP) protocols used for the isolation and expansion of chondrocytes by the Oswestry/Keele University Orthopaedic Research (OsKOR) group and John Charnley GMP and MHRA licensed laboratory, both based at the RJAH Orthopaedic Hospital, Oswestry, UK.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Harrison PE, Ashton IK, Johnson WE et al (2000) The in vitro growth of human chondrocytes. Cell Tissue Bank 1(4):255–260. https://doi.org/10.1023/a:1010131729208

    Article  CAS  PubMed  Google Scholar 

  2. Garcia J, Mennan C, McCarthy HS et al (2016) Chondrogenic potency analyses of donor-matched chondrocytes and mesenchymal stem cells derived from bone marrow, infrapatellar fat pad, and subcutaneous fat. Stem Cells Int 2016:6969726. https://doi.org/10.1155/2016/6969726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mennan C, Garcia J, McCarthy H et al (2019) Human articular chondrocytes retain their phenotype in sustained hypoxia while normoxia promotes their immunomodulatory potential. Cartilage 10(4):467–479. https://doi.org/10.1177/1947603518769714

    Article  CAS  PubMed  Google Scholar 

  4. Jakob M, Démarteau O, Schäfer D et al (2001) Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 81(2):368–377. https://doi.org/10.1002/1097-4644(20010501)81:2<368::aid-jcb1051>3.0.co;2-j

    Article  CAS  PubMed  Google Scholar 

  5. Brittberg M, Lindahl A, Nilsson A et al (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331(14):889–895. https://doi.org/10.1056/nejm199410063311401

    Article  CAS  PubMed  Google Scholar 

  6. Richardson JB, Caterson B, Evans EH et al (1999) Repair of human articular cartilage after implantation of autologous chondrocytes. J Bone Joint Surg Br 81(6):1064–1068. https://doi.org/10.1302/0301-620x.81b6.9343

    Article  CAS  PubMed  Google Scholar 

  7. Davies RL, Kuiper NJ (2019) Regenerative medicine: a review of the evolution of autologous chondrocyte implantation (ACI) therapy. Bioengineering (Basel) 6(1):22. https://doi.org/10.3390/bioengineering6010022

    Article  CAS  Google Scholar 

  8. National Institute for Health and Care Excellence (NICE) (2017) Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee. Technology appraisal guidance [TA477]. https://www.nice.org.uk/guidance/ta477/resources/autologous-chondrocyte-implantation-for-treating-symptomatic-articular-cartilage-defects-of-the-knee-pdf-82604971061701

  9. Mistry H, Connock M, Pink J et al (2017) Autologous chondrocyte implantation in the knee: systematic review and economic evaluation. Health Technol Assess 21(6):1–294. https://doi.org/10.3310/hta21060

    Article  PubMed  PubMed Central  Google Scholar 

  10. EudraLex. Volume 4 – Good manufacturing practice (GMP) guidelines. (2011–2015). https://ec.europa.eu/health/documents/eudralex/vol-4_en

Download references

Acknowledgements

We would like to acknowledge the contributions made to this book chapter from all of the Oswestry/Keele University Orthopaedic Research (OSKOR) group and John Charnley GMP and MHRA licensed laboratory, both based at the RJAH Orthopaedic Hospital, Oswestry, UK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karina Wright .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Harrison, P., Hopkins, T., Hulme, C., McCarthy, H., Wright, K. (2023). Chondrocyte Isolation and Expansion. In: Stoddart, M.J., Della Bella, E., Armiento, A.R. (eds) Cartilage Tissue Engineering. Methods in Molecular Biology, vol 2598. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2839-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2839-3_2

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2838-6

  • Online ISBN: 978-1-0716-2839-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics